Firms
Theme

HBANL

Huntington Bancshares Incorporated Depositary Shares, Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock · NASDAQ

News

6 latest

No direct coverage yet · Showing articles that mention HBANL

Zacks Investment Research

Huntington Q3 Earnings Match Estimates as NII & Fee Income Rise Y/Y

Huntington Bancshares (HBAN) reported Q3 2026 adjusted EPS of 38 cents matching estimates, with revenues up 30.7% to $2.81 billion. While net interest income jumped 37.2% and NIM expanded 12 basis points, the company faced headwinds from surging non-interest expenses (up 42.2%), deteriorating credit quality with net charge-offs rising to $146 million, and declining average loan balances. The efficiency ratio worsened to 61.2%, and capital ratios declined year-over-year, prompting a Zacks Rank #5 (Strong Sell) rating.

Zacks Investment Research

Huntington Bancshares (HBAN) Meets Q3 Earnings Estimates

Huntington Bancshares reported Q3 2026 earnings of $0.38 per share, matching consensus estimates but missing revenue expectations with $2.81 billion versus the estimated $2.82 billion. The stock has underperformed the S&P 500 by 22.7% year-to-date and carries a Zacks Rank #5 (Strong Sell) rating due to unfavorable estimate revisions, suggesting continued underperformance ahead.

Zacks Investment Research

Huntington Q3 Earnings on Deck: Here's What Investors Should Expect

Huntington Bancshares (HBAN) is expected to report Q3 2026 results on July 23 with revenues projected to rise 31.2% year-over-year, but earnings are anticipated to fall 5%. While net interest income and non-interest income are expected to grow, higher personnel costs, technology investments, and loan-loss provisions are likely to pressure profitability. The company carries a Zacks Rank of 5 (Strong Sell) with an Earnings ESP of -0.47%, suggesting no earnings beat is predicted.

Zacks Investment Research

German American Bancorp (GABC) Earnings Expected to Grow: What to Know Ahead of Q3 Release

German American Bancorp is expected to report Q3 2026 earnings of $1.01 per share, representing a 9.8% year-over-year increase, with revenues projected at $102.46 million, up 8.8%. The company has a positive Earnings ESP of +3.23% combined with a Zacks Rank #3 (Hold), suggesting it will likely beat consensus estimates. The company has beaten EPS estimates in 3 of the last 4 quarters.

Zacks Investment Research

Earnings Preview: Huntington Bancshares (HBAN) Q3 Earnings Expected to Decline

Huntington Bancshares is expected to report Q3 2026 earnings of $0.38 per share, representing a 5% year-over-year decline, though revenues are projected to rise 31.2% to $2.82 billion. The consensus EPS estimate has been revised 6.75% lower over the last 30 days. With an Earnings ESP of 0% and a Zacks Rank of #5, the stock is not considered a compelling earnings-beat candidate.

Zacks Investment Research

Can Nolan & Associates Deal Fortify Commerce Bancshares' Fee Income?

Commerce Bancshares (CBSH) has completed its acquisition of Nolan & Associates, adding investment banking and M&A advisory capabilities to strengthen its middle-market franchise. The deal enables CBSH to generate fee-based revenues from advisory and transaction services while cross-selling banking products to existing clients. The acquisition complements CBSH's broader diversification strategy and mirrors similar moves by regional banks like Huntington Bancshares and Regions Financial to expand advisory-driven revenue streams.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $HBANL · 0 threads

Sign in to post on $HBANL

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev